CLINICAL_TRIALS trial_result · 2013-05-31

Clinical Trial Update: Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes [Phase 2]

A Phase 2 study evaluating the efficacy and safety of MP-513 in adults with Type 2 diabetes. The results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2013-05-31